Skip to main content
Equibles

ADAGE CAPITAL PARTNERS GP, L.L.C.

Position in NBP — NovaBridge Biosciences

CIK 1165408 Boston, MA
Back to NBP Full portfolio

Position in NBP

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$1,950,000
-$510,000 QoQ
Shares Held
1,000,000
0.0% QoQ
Ownership
0.865%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#7
of 49 holders
Holding Since
Mar 2020
14 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in NBP Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

ADAGE CAPITAL PARTNERS GP, L.L.C. holds $4,240,035,723 across 125 Biotechnology names. NBP ranks #112 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ROIV
Roivant Sciences Ltd.
 10,349,328 $366,262,717
2 PRAX
Praxis Precision Medicines, Inc.
 1,015,480 $339,972,549
3 VRTX
Vertex Pharmaceuticals Inc / Ma
 393,964 $195,693,737
4 TNGX
Tango Therapeutics, Inc.
 5,600,000 $175,056,000
5 BBIO
BridgeBio Pharma, Inc.
 2,252,000 $167,728,960
6 SYRE
Spyre Therapeutics, Inc.
 1,722,300 $152,905,794
7 TVTX
Travere Therapeutics, Inc.
 2,569,356 $145,965,114
8 RPRX
Royalty Pharma plc
 2,500,000 $140,175,000

All Filings in NBP

Export CSV
14 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,950,000 1,000,000
2026-03-31 $2,460,000 1,000,000
2025-12-31 $3,980,000 1,000,000
2025-09-30 $12,617,768 3,338,034
2022-06-30 $10,170,000 900,000
2022-03-31 $22,736,000 1,400,000
2021-12-31 $66,346,000 1,400,000
2021-09-30 $86,981,185 1,199,906
2021-06-30 $69,250,858 824,906
2021-03-31 $58,973,158 1,216,694
2020-12-31 $66,212,745 1,404,300
2020-09-30 $55,498,786 1,180,072
2020-06-30 $33,441,297 1,117,317
2020-03-31 $13,000,000 1,000,000